Eating Disorders Trial, Recruiting NCT04107870 Sponsor: CHU de Reims Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT04107870
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a female teenager between the ages of 13 and 18
  • You have been diagnosed with anorexia nervosa (any type, including purging or binge-eating forms) according to standard medical guidelines (DSM-V)
  • French is your first language
  • You agree to take part in the study
  • The person or people with parental responsibility over you agree to your participation
  • You are covered by the French social security system (or equivalent)

Who may not be able to join:

  • You are completely unable to eat or swallow any food
  • Your body weight is dangerously low for your age (specific cut-off weights apply depending on your age — confirm with trial site)
  • You are experiencing confusion or a severely altered mental state
  • Your heart rate is too slow (under 40 beats per minute) or too fast
  • Your blood pressure is very low (below 80/50 mmHg)
  • Your body temperature is dangerously low (below 35.5°C)
  • You have serious problems with the levels of certain minerals or salts in your blood, such as potassium, sodium, or phosphate being too low or too high
  • You have dangerously low blood sugar or certain substances in your urine that indicate your body is breaking down fat in an unhealthy way
  • Your kidneys or liver are not functioning properly, based on blood test results
  • Your white blood cell count or platelet count is dangerously low
  • You have attempted suicide in the month before joining the study
  • You are taking a certain type of calming medication (benzodiazepines) outside of what has been prescribed for you
  • You have been diagnosed with a psychotic disorder or addiction to drugs or alcohol (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03 26 78 39 56

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CHU de Reims
Registry
ClinicalTrials.gov
Start date
20 June 2021
Est. completion
20 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Body Shape Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov